Glessner Coleen - Insider Non-Derivative Transactions at Emergent BioSolutions Inc. (EBS) - (SEC)

Updated on January 3, 2026.

According to recent SEC insider information filed on Oct 7, 2025, Glessner Coleen's relationship to Emergent BioSolutions Inc. (EBS) is Officer (EVP, Quality & Ethics, and CPL), and currently has 144,319 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other EBS insiders.

Related Topics: SEC Topic List.

Data Source: SEC.

Glessner Coleen - Insider Non-Derivative Transactions of EBS Common Stock

Glessner Coleen - Insider Non-Derivative Transactions at EBS

Items per page:

0 of 0

Date	Transaction	No. of Shares	Price Per Share	Shares Owned After Transactions
Oct 8, 2025	Sell -- (Common Stock)	30608	10	144319
Jun 9, 2025	F -- (Common Stock)	1249	6.63	174927
Apr 8, 2025	F -- (Common Stock)	480	4.44	176176
Mar 7, 2025	Acquisition -- (Common Stock)	62500	0	176656
Mar 2, 2025	F -- (Common Stock)	313	7.48	114156
Feb 13, 2025	Disposition -- (Common Stock)	24078	0	114469
Feb 13, 2025	Disposition -- (Common Stock)	5913	0	138547
Dec 9, 2024	F -- (Common Stock)	18674	9.01	144460
Jun 9, 2024	F -- (Common Stock)	1249	6.19	163134
Apr 8, 2024	F -- (Common Stock)	585	2.29	164383
Mar 2, 2024	F -- (Common Stock)	381	3.39	164968
Jun 10, 2023	Acquisition -- (Common Stock)	15385	0	134579
Jun 10, 2023	Acquisition -- (Common Stock)	30770	0	165349
Apr 8, 2023	F -- (Common Stock)	480	0	120154
Mar 3, 2023	Acquisition -- (Common Stock)	3846	0	111982
Mar 3, 2023	Acquisition -- (Common Stock)	7692	0	119674